CIBAR1P2: A Potential Drug Target for Various Diseases (G403315)

Target Name: CIBAR1P2

NCBI ID: G403315

CIBAR1P2

Other Name(s): FAM92A1P2 | FAM92A3 | CIBAR1 pseudogene 2

CIBAR1P2: A Potential Drug Target for Various Diseases

CIBAR1P2 (FAM92A1P2) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its primary function is to regulate the blood flow to the body's tissues, which is critical for maintaining the delivery of oxygen and nutrients to the cells that need them.

CIBAR1P2 is a member of the FAM92A family of proteins, which are known for their role in regulating blood flow and pressure. The FAM92A family has been identified as a potential drug target for various diseases, including heart failure, hypertension, and diabetes.

One of the unique features of CIBAR1P2 is its ability to regulate blood flow in a dynamic and responsive manner. This is accomplished through a protein called P2, which is located on the surface of the CIBAR1P2 molecule. P2 is a G protein-coupled receptor (GPCR), which allows CIBAR1P2 to interact with various signaling molecules in the body.

Studies have shown that changes in the expression of CIBAR1P2 can have a significant impact on the development and progression of various diseases. For example, research has suggested that increased expression of CIBAR1P2 may contribute to the development of cancer by promoting the growth and survival of cancer cells.

In addition to its role in cancer, CIBAR1P2 has also been shown to be involved in a number of other important physiological processes in the body. For example, it has been shown to play a key role in the regulation of blood pressure, and that changes in its expression can have a significant impact on the risk of heart disease.

Given the potential role of CIBAR1P2 in a variety of diseases, it is an attractive target for drug development. Researchers are currently working to identify small molecules that can modulate the activity of CIBAR1P2, with the goal of developing new treatments for a range of diseases.

In conclusion, CIBAR1P2 is a protein that has the potential to be a drug target for a variety of diseases. Its role in regulating blood flow and pressure makes it an attractive target for small molecule inhibitors, and its involvement in a number of important physiological processes makes it a promising target for the development of new treatments. Further research is needed to fully understand the role of CIBAR1P2 in disease and to develop effective treatments.

Protein Name: CIBAR1 Pseudogene 2

The "CIBAR1P2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CIBAR1P2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets